Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
22,465,656
-
Total 13F shares
-
2,150,633
-
Share change
-
+2,066,952
-
Total reported value
-
$4,086,190
-
Price per share
-
$1.90
-
Number of holders
-
49
-
Value change
-
+$4,064,929
-
Number of buys
-
47
-
Number of sells
-
2
Institutional Holders of X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR) as of Q2 2025
As of 30 Jun 2025 X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR) had 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,150,633 shares of stock of the company.
Largest 10 holders included Bain Capital Life Sciences Investors, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., VANGUARD GROUP INC, BlackRock, Inc., GSA CAPITAL PARTNERS LLP, UBS Group AG, JANE STREET GROUP, LLC, BANK OF AMERICA CORP /DE/, OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC), and MILLENNIUM MANAGEMENT LLC.
This table shows 49 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.